$JILL

Rolfe Andrew sold (to issuer) 8,341 shares of JILL

Rolfe Andrew sold (to issuer) 8,341 shares of J.Jill, Inc. (JILL) on 2026-06-03.

Original reporting
SEC EDGAR · Rolfe Andrew
Published Jun 5, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$JILL
Neutral
medium confidence
Mentioned
$JILL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JILLNeutralLow
01

Why it matters

Updates insider holdings (post-transaction holdings: 19,343 shares) but provides limited actionable signal without price/value or stated rationale.

02

Market read

Traders may monitor for follow-on insider activity, but this single Form 4 typically has limited impact absent other catalysts.

03

What to watch

No disclosed transaction price/value and no stated reason for the sale; also no 10b5-1 plan details, limiting inference about intent.

Relevance 4/10Novelty 3/10Timing: Filed June 5 for a June 3 insider sale transaction

Background

The article is a SEC Form 4 insider transaction disclosure for J.Jill, Inc., reporting a director’s sale to the issuer.

Company-level read

Ticker impact

$JILLNeutralMedium confidence
Context

Director Rolfe Andrew sold 8,341 shares in a Form 4 sale-to-issuer transaction, changing insider ownership in J.Jill.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any reaction is likely muted.

Evidence & confidence

The filing discloses share count and that price/value aren’t disclosed, with no 10b5-1 plan cited; insider transactions often have limited standalone impact unless unusually large or paired with other material events.

Market effects

Minimal; this is company-specific insider activity with no sector-wide read-across provided.

None indicated.

None indicated.

Counterpoint

If the sale is not purely mechanical, it could reflect near-term caution; however, the “sale to issuer” code often reduces interpretability.

Key entities

  • J.Jill, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Rolfe Andrew

    Director who sold 8,341 shares via sale-to-issuer transaction.

Related articles

$JILLMedAI 8/10

J.Jill Reaffirms FY26 Outlook, But Stock Plunges 7.6%

J.Jill reported first-quarter results and set Q2 guidance, expecting net sales to fall 1%–3% and comparable sales to decline 2%–4%. The company also reaffirmed its FY2026 outlook for net sales flat to down 2% and comparable sales down 1%–3%, based on assumed reciprocal tariff rates and lower second-half inventory purchases. The stock fell about 7.6% premarket to $12.10.

$JILLMed

J.Jill, Inc. (JILL): Results of Operations and Financial Condition

J.Jill, Inc. (JILL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 jill-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 J.JILL, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS Provides Q2 FY26 Outlook Reaffirms Full Year FY26 Sales and Adjusted EBITDA* Outlook Quincy, Mass – June 10, 2026 – J.Jill, Inc. (NYSE:JILL) ("J.Jill" or the "Company") today